Sign in
Username
Password
Lost your password?
Login
Login with Facebook
Login with Google
Login with LinkedIn
(close)
Search for:
Sign in
Register
Country Reports
InFocus
Europe
Asia-Pacific
Americas
Middle East & Africa
Legal & Regulatory
Sign in / Register
Country Reports
Americas
Asia-Pacific
Europe
Middle East & Africa
Vaccines
Legal & Regulatory
Shop
Search for:
Library
Contributions
China
COVID-19
Cell & Gene Therapy
Vaccines
News Releases
Facts & Figures
Directory
Shop
Tagged with Zydus Cadila
Mexico Looks to India to Bolster Domestic Supply Chain post-COVID
COVID-19 has highlighted the importance of secure regional pharma supply chains across the globe, not least in Mexico where the state of Hidalgo has…
Save
Share
Six Indian Companies at the Forefront of COVID-19 Vaccine…
Six Indian pharma and biotech firms have joined the global race to develop a vaccine for COVID-19 with India-developed vaccine candidates moving…
Save
Share
Indian Generics in the USA: Destined for More Success?
A recent IQVIA report highlights the increasing importance of Indian firms to the USA’s burgeoning generic pharmaceuticals market. Now…
Save
Share
Gujarat: The Home of Indian Pharma
The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the country’s pharmaceutical turnover…
Save
Share
Juan Luis Fernández Balaguer – General Manager,…
Juan Luis Fernández Balaguer, general manager of Laboratorios Combix, the Spanish affiliate of Zydus Cadila, shares the milestones achieved by the…
Save
Share
Top 15 Pharma Companies in India Ranking
The top 15 pharma companies in India for 2017 ranked by market share and growth rate. Homegrown champions Sun Pharma, Cipla and Zydus Cadila lead the…
Save
Share
Sharvil Patel – Managing Director, Zydus Cadila
As managing director of India’s fifth largest pharmaceutical company, Zydus Cadila’s Sharvil Patel shares his insights on his impressive…
Save
Share
Indian Biosimilars: Going Global
Deloitte predicts that the global market for biosimilars will reach between USD 25 and 35 billion by 2020, driven by some key global biologic drugs…
Save
Share
We use cookies to ensure that we give you the best experience on our site. For more info
click here
ACCEPT